Germany vs Sweden: Proportion of isolates with decreased susceptibility or resistance
Germany
1
in 2018
Sweden
1.5
in 2018
Germany rank
12th
Sweden rank
9th
Proportion of isolates with decreased susceptibility or resistance over time
- Germany
- Sweden
How they compare
Sweden currently reports 1.5 against 1 in Germany, a difference of 0.5.
That makes Sweden's figure about 1.5 times Germany's.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was Sweden ahead.
Germany ranks 12th and Sweden ranks 9th of 27 countries.
Across the 2 decades both report, Germany averaged higher in 1 and Sweden in 1.
Head to head by decade
| Decade | Germany | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.22 | 2.78 | 0.5556 | Sweden |
| 2010s | 5.66 | 2.03 | 3.63 | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Germany or Sweden?
- Sweden, at 1.5 against 1 in Germany as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Germany and Sweden?
- 0.5, with Sweden ahead.
- How many years of comparable data are there for Germany and Sweden?
- 10 years are reported by both, from 2009 to 2018.
- How do Germany and Sweden rank globally for proportion of isolates with decreased susceptibility or resistance?
- Germany ranks 12th and Sweden ranks 9th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.